Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
about
Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure.Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis.A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controll
P2860
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and tolerability of f ...... prospective, crossover study.
@ast
Efficacy and tolerability of f ...... prospective, crossover study.
@en
Efficacy and tolerability of f ...... prospective, crossover study.
@nl
type
label
Efficacy and tolerability of f ...... prospective, crossover study.
@ast
Efficacy and tolerability of f ...... prospective, crossover study.
@en
Efficacy and tolerability of f ...... prospective, crossover study.
@nl
prefLabel
Efficacy and tolerability of f ...... prospective, crossover study.
@ast
Efficacy and tolerability of f ...... prospective, crossover study.
@en
Efficacy and tolerability of f ...... prospective, crossover study.
@nl
P2093
P2860
P356
P1433
P1476
Efficacy and tolerability of f ...... prospective, crossover study.
@en
P2093
Alfonso García-López
Curt Hartleben
Jesús Jiménez-Román
José A Paczka
P2860
P2888
P356
10.1186/1471-2415-14-161
P577
2014-12-19T00:00:00Z
P5875
P6179
1000297153